Harmony Biosciences Holdings (HRMY) Equity Ratio: 2019-2025
Historic Equity Ratio for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to 0.69.
- Harmony Biosciences Holdings' Equity Ratio rose 7.49% to 0.69 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.69, marking a year-over-year increase of 7.49%. This contributed to the annual value of 0.66 for FY2024, which is 14.63% up from last year.
- Per Harmony Biosciences Holdings' latest filing, its Equity Ratio stood at 0.69 for Q3 2025, which was down 0.93% from 0.70 recorded in Q2 2025.
- In the past 5 years, Harmony Biosciences Holdings' Equity Ratio registered a high of 0.70 during Q2 2025, and its lowest value of 0.32 during Q1 2021.
- In the last 3 years, Harmony Biosciences Holdings' Equity Ratio had a median value of 0.64 in 2023 and averaged 0.64.
- Per our database at Business Quant, Harmony Biosciences Holdings' Equity Ratio soared by 89.10% in 2021 and then dropped by 3.73% in 2023.
- Over the past 5 years, Harmony Biosciences Holdings' Equity Ratio (Quarterly) stood at 0.43 in 2021, then skyrocketed by 38.93% to 0.60 in 2022, then fell by 3.73% to 0.58 in 2023, then climbed by 14.63% to 0.66 in 2024, then increased by 7.49% to 0.69 in 2025.
- Its last three reported values are 0.69 in Q3 2025, 0.70 for Q2 2025, and 0.68 during Q1 2025.